Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes - 25/02/25
, Kaifeng Wang d, ⁎ Abstract |
Background |
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide, leading to substantial disease burden globally. Whether sleep duration is associated with the risk of MASLD, cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality remains underexplored.
Methods |
A total of 489,261 middle-aged and older adults from the UK Biobank without prior liver diseases were included. The primary outcome was MASLD, with secondary outcomes, including cirrhosis, HCC, and liver-related mortality ascertained through linked hospital records and death registries. Sleep duration was self-reported at baseline survey and categorized into ≤ 5, 6, 7, 8 and ≥ 9 hours.
Results |
During a median (IQR) follow-up of 13.8 (1.5) years, 7,133 MASLD, 5,527 cirrhosis, 1,126 HCC, and 1,125 liver-related mortality cases were identified. After adjusting for potential confounders, the HRs [95% CIs] of MASLD were 1.44 [1.32;1.57], 1.17 [1.09;1.24], 1.00 (reference), 1.05 [0.99;1.11] and 1.35 [1.24;1.46] for ≤ 5, 6, 7, 8 and ≥ 9 hours of sleep duration, respectively. Similar trends were also observed for cirrhosis, HCC, and liver-related mortality. In addition, the U-shaped association between sleep duration and MASLD was more pronounced among participants without abnormal body mass index (overweight and obese), hypertension or insomnia (P for interaction <0.05).
Conclusions |
Both short and long sleep duration are associated with an increased risk of MASLD, cirrhosis, HCC, and liver-related mortality. Maintaining a moderate sleep duration of 7 to 8 hours per day could be crucial to prevent against this escalating public health concern.
Le texte complet de cet article est disponible en PDF.Keywords : Epidemiology, Hepatocellular carcinoma, Liver cirrhosis, Metabolic dysfunction–associated steatotic liver disease, Metabolic dysfunction–associated steatohepatitis, Sleep duration
Plan
| ☆ | Abbreviation list: MASLD, metabolic dysfunction-associated steatotic liver disease; UK, United Kingdom; HCC, hepatocellular carcinoma; BMI, body mass index; IQR, interquartile range; HR, hazard ratio; CI, confidence interval; MASH, metabolic dysfunction-associated steatohepatitis; ICD, International Classification of Diseases; WHO, World Health Organization; NHS, National Health Service; SMD, standardized mean difference; NAFLD, non-alcoholic fatty liver disease; ALT, alanine amino transferase; AST, aspartate transaminase; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG fasting blood glucose; TG, triglycerides; HbA1c, glycated hemoglobin. |
Vol 51 - N° 3
Article 101628- mai 2025 Retour au numéro
Article précédent
- Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus
- Talia Diker Cohen, Yaron Rudman, Adi Turjeman, Amit Akirov, Tali Steinmetz, Bronya Calvarysky, Idit Dotan
- Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data
- Emmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, Karine Clément, Martine Laville, Cyril Gauthier, François Pattou, Julie Molleville, Melissa Akerib, Lysiane Jubin, Blandine Gatta-Cherifi, Bénédicte Gaborit, Emilie Montastier, Fabien Stenard, Claire Carette, Najate Achamrah, Antoine Avignon, Sébastien Czernichow, SEMAFEAP Study Group, Camille Sollier, Bérénice Segrestin, Anne Dutour, Jean-Baptiste Bonnet, Charles Barsamian, Pierre Belassen, Diana Shenouda, Ana Estrade, Alain Pradignac, Vanessa Folope, Najate Achamrah, Naima Oukhouyadaoud, Rudy Caillet, Mohamed Zerguine, Marie-Claude Brindisi, Séverine Ledoux, Maud Monsaingeon-Henry, Agnès Sallé, Magalie Miolanne, Mickael Som, Séverine Andrieux, Marion Bretault, Anne-Cécile Paepegaey, Yann Matussiere, Anne-Laure Sberna, Geraldine Vitellius, Syrine Jarraya, Nicolas Chevalier, Véronique Taillard, Anca Montagnier, Marie Guillouche, Géraldine Lévy, Pauline Suzeau, Alexandre Schwanke, Héléna Mosbah, Geoffroy Boulate, Said Bekka, Laurène Bosc, Ibrahim Hamadeh, Thomas Leroi, Virginie Castera, Frédérique Olivier, Vincent Appavoupoulle, Alexandre Jehl, Océane Lheveder, Marie-Laure Lalanne-Mistrih, Audrey Lamoliate, Patricia Degrelle, Jean-Sébastien Lanne, Nadia Sabbah, Elias Barrak, Lise Pagniez, Salvatore Avallone, Dominique Boute, Lyse Bordier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?